OpRegen
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for OpRegen, covering 2023-03-06 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251 [Phase 2]